Published in Curr Rheumatol Rep on August 01, 2011
Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) (2012) 1.15
Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs (2014) 1.00
Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set. RMD Open (2016) 0.88
Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries? Clin Rheumatol (2017) 0.75
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13
Repair of radiographic joint damage following treatment with etanercept in psoriatic arthritis is demonstrable by 3 radiographic methods. J Rheumatol (2011) 2.07
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. Am J Hum Genet (2012) 1.88
Diffuse idiopathic skeletal hyperostosis in psoriatic arthritis. J Rheumatol (2013) 1.51
Qualifying unmet needs and improving standards of care in psoriatic arthritis. Arthritis Care Res (Hoboken) (2014) 1.43
Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res (Hoboken) (2011) 1.35
Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford) (2011) 1.26
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol (2007) 1.11
TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. J Invest Dermatol (2011) 1.10
Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care Res (Hoboken) (2010) 1.06
Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis (2011) 1.06
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures. J Rheumatol (2007) 1.04
Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis (2011) 1.02
Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol (2008) 0.98
Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) (2011) 0.96
Effect of lead exposure on the immune response of some occupationally exposed individuals. Toxicology (2003) 0.95
Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Ann Rheum Dis (2012) 0.95
Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken) (2011) 0.93
Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol (2014) 0.90
Application of higher order statistics/spectra in biomedical signals--a review. Med Eng Phys (2010) 0.89
Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis? Ann Rheum Dis (2010) 0.88
Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. J Rheumatol (2008) 0.88
Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis. Ann Rheum Dis (2013) 0.88
Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol (2012) 0.88
IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients. Ann Rheum Dis (2011) 0.87
Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford) (2010) 0.86
Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era. J Rheumatol (2013) 0.85
Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity. J Rheumatol (2011) 0.85
Patient-reported outcome in psoriatic arthritis: a comparison of Web-based versus paper-completed questionnaires. J Rheumatol (2011) 0.84
The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis (2011) 0.84
Plasma adipokine levels and their association with overall burden of painful joints among individuals with hip and knee osteoarthritis. J Rheumatol (2013) 0.84
Management of comorbidities in ankylosing spondylitis. Am J Med Sci (2012) 0.83
Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Ann Rheum Dis (2012) 0.82
Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease. Clin Chem Lab Med (2013) 0.82
Epidemiology of psoriatic arthritis. J Rheumatol (2009) 0.82
Time and predictors of response to tumour necrosis factor-alpha blockers in psoriatic arthritis: an analysis of a longitudinal observational cohort. Rheumatology (Oxford) (2010) 0.82
Arthritis mutilans. Curr Rheumatol Rep (2013) 0.81
The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone. Ann Rheum Dis (2012) 0.81
Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study. Ann Rheum Dis (2012) 0.81
Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology (Oxford) (2010) 0.81
Identification of gastroenteric viruses by electron microscopy using higher order spectral features. J Clin Virol (2005) 0.80
Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis. Ann Rheum Dis (2010) 0.80
Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes. Arthritis Care Res (Hoboken) (2011) 0.80
Psoriasis and psoriatic arthritis in Peruvian aborigines: a report from the GRAPPA 2011 annual meeting. J Rheumatol (2012) 0.79
Is the MAdrid Sonographic Enthesitis Index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls? J Rheumatol (2014) 0.79
Decision support system for age-related macular degeneration using discrete wavelet transform. Med Biol Eng Comput (2014) 0.78
Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. J Rheumatol (2013) 0.78
Delineating the synovial fluid proteome: recent advancements and ongoing challenges in biomarker research. Crit Rev Clin Lab Sci (2013) 0.78
Reliability of radiographic scoring methods in axial psoriatic arthritis. Arthritis Care Res (Hoboken) (2014) 0.78
Current controversies in spondyloarthritis: SPARTAN. J Rheumatol (2010) 0.77
Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting. J Rheumatol (2011) 0.77
Spondyloarthritis: CASPAR criteria in early psoriatic arthritis. Nat Rev Rheumatol (2012) 0.77
Psoriatic arthritis in Canadian clinical practice: the PsA assessment in rheumatology. J Rheumatol (2012) 0.77
Soluble endothelial cell adhesion molecules and their relationship to disease activity in Takayasu's arteritis. J Rheumatol (2008) 0.76
Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care Res (Hoboken) (2015) 0.76
How can psoriatic arthritis be diagnosed early? Curr Rheumatol Rep (2012) 0.75
Physician scores vs patient self-report of joint and skin manifestations in psoriatic arthritis. Rheumatology (Oxford) (2012) 0.75
The effectiveness of leflunomide in psoriatic arthritis. Clin Exp Rheumatol (2014) 0.75
Cardiac health diagnosis using higher order spectra and support vector machine. Open Med Inform J (2009) 0.75
Novel serum biomarkers differentiate psoriatic arthritis from psoriasis without psoriatic arthritis. Arthritis Care Res (Hoboken) (2017) 0.75
The genetic basis of spondyloarthritis: SPARTAN/IGAS 2009. J Rheumatol (2010) 0.75
Ensemble Methods for Classification of Physical Activities from Wrist Accelerometry. Med Sci Sports Exerc (2017) 0.75
Which is worse in psoriasis - skin or joints? Int J Rheum Dis (2015) 0.75
Does the change in season affect disease activity in patients with psoriatic arthritis? Ann Rheum Dis (2012) 0.75
Magnetic Resonance Imaging in Psoriatic Arthritis: A Descriptive Study of Indications, Features and Effect on Treatment Change. J Clin Rheumatol (2017) 0.75
Investigational drugs for treating psoriatic arthritis. Expert Opin Investig Drugs (2014) 0.75
What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis? Curr Opin Rheumatol (2015) 0.75
Physical Activity Recognition using Posterior-adapted Class-based Fusion of Multi-Accelerometers data. IEEE J Biomed Health Inform (2017) 0.75